Otmar D. Wiestler
Director/Board Member en BAYER AG .
Perfil
Otmar D.
Wiestler is on the board of Bayer AG and Mark Foundation and Chairman of Technische Universität München and President of Helmholtz-Gemeinschaft Deutscher Forschungszentren eV.
Dr. Wiestler previously occupied the position of Chairman-Management Board & Scientific Director at German Cancer Research Center and Professor at the University of Bonn.
Dr. Wiestler received a doctorate from the University of Freiburg.
Cargos activos de Otmar D. Wiestler
Empresas | Cargo | Inicio |
---|---|---|
BAYER AG | Director/Board Member | 09/10/2014 |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | President | 01/09/2015 |
Technische Universität München | Chairman | 01/01/2016 |
Mark Foundation
Mark Foundation Miscellaneous Commercial ServicesCommercial Services The Mark Foundation for Cancer Research is a charitable organization that partners with scientists worldwide to accelerate research for the prevention, diagnosis, and treatment of cancer. The Mark Foundation is based in New York, NY and was founded by Alexander Mark Knaster. The foundation has awarded over $200 million in grants to more than 100 academic institutions across 13 countries since 2017. The non-profit company's research programs focus on early career support, team science collaboration, new technology innovation, and therapeutics discovery. The foundation also invests in early-stage cancer diagnostics and therapeutics companies. | Director/Board Member | 10/05/2023 |
Antiguos cargos conocidos de Otmar D. Wiestler.
Empresas | Cargo | Fin |
---|---|---|
German Cancer Research Center
German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Chief Executive Officer | 01/01/2015 |
University of Bonn | Corporate Officer/Principal | 01/01/2003 |
LIFE & BRAIN GmbH
LIFE & BRAIN GmbH Miscellaneous Commercial ServicesCommercial Services LIFE & BRAIN GmbH operates as a development-stage biomedical company. The firm develops novel strategies for the diagnosis and therapy of nervous system disorders. It offers its products and services in different business units: LIFE & BRIAN CellSolutions, Genomics, NeuroEconomics and Electrophysiology services. The company is headquartered in Bonn, Germany. | Chief Tech/Sci/R&D Officer | 01/01/2003 |
Formación de Otmar D. Wiestler.
University of Freiburg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BAYER AG | Health Technology |
Empresas privadas | 4 |
---|---|
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | Commercial Services |
German Cancer Research Center
German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Health Services |
LIFE & BRAIN GmbH
LIFE & BRAIN GmbH Miscellaneous Commercial ServicesCommercial Services LIFE & BRAIN GmbH operates as a development-stage biomedical company. The firm develops novel strategies for the diagnosis and therapy of nervous system disorders. It offers its products and services in different business units: LIFE & BRIAN CellSolutions, Genomics, NeuroEconomics and Electrophysiology services. The company is headquartered in Bonn, Germany. | Commercial Services |
Mark Foundation
Mark Foundation Miscellaneous Commercial ServicesCommercial Services The Mark Foundation for Cancer Research is a charitable organization that partners with scientists worldwide to accelerate research for the prevention, diagnosis, and treatment of cancer. The Mark Foundation is based in New York, NY and was founded by Alexander Mark Knaster. The foundation has awarded over $200 million in grants to more than 100 academic institutions across 13 countries since 2017. The non-profit company's research programs focus on early career support, team science collaboration, new technology innovation, and therapeutics discovery. The foundation also invests in early-stage cancer diagnostics and therapeutics companies. | Commercial Services |